Vaishali Pharma Limited — AGM Information 2025

Sep 22, 2025

Date: 22[nd] September, 2025

To, National Stock Exchange of India Limited, Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai- 400051

NSE Symbol: VAISHALI

Sub: Proceedings of 18[th] (Eighteenth) Annual General Meeting of the Company.

Dear Sir/Madam,

The 18[th] (Eighteenth) Annual General Meeting (‘ AGM’ ) of Vaishali Pharma Limited (‘ the Company ’) was held today i.e. Monday, 22[nd] September, 2025 which was commenced at 11:00 A.M and concluded at 11:15 A.M. through Video Conference (‘VC’)/ Other Audio-Visual Means (‘OAVM’) in accordance with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India.

The requisite quorum being present, the Chairman called the Meeting to order.

The Notice convening Annual General Meeting was taken as read.

The Members were informed that in accordance with the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 and Regulation 44 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘ SEBI LODR ’) the Company had provided remote e-voting facility to its Members for casting of votes through electronic means. The remote e-voting commenced at 09:00 A.M. on Friday, 19[th ] September, 2025 and ended at 05:00 P.M. on Sunday, 21[st ] September, 2025. The facility for e-voting was also made available at the AGM, in accordance with the provisions on e-voting framed under the Companies Act, 2013, for Members who had not cast their vote through remote e-voting.

The following business items as set out in the Notice convening the AGM were transacted at the AGM:

Sr. No.	Details of the Items	Resolution Type (Ordinary/ Special)
	ORDINARY BUSINESS
1.	Adoption of the Audited Financial Statements of the Company for the financial year ended 31stMarch, 2025 together with the reports of Directors and Auditors thereon.	Ordinary
2.	To consider appointment of a Director, Mr. Dewansh Vasani (DIN: 08111804), liable to retire by rotation, and being eligible, offers herself for re-appointment.	Ordinary
	SPECIAL BUSINESS
3.	Approval for appointment of HD & Associates as Secretarial Auditor of the Company.	Ordinary

Details of Voting Results as required under Regulation 44(3) of the SEBI Listing Regulations will be submitted separately.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following are the details of AGM:

1.	Date of AGM	22ndSeptember,2025
2.	Total Number of Shareholders as on Record Date	28,389
3.	No of Shareholders Present in the meeting either in person or through proxy: • Promoters and Promoter Group • Public	Not Applicable
4.	No of Shareholders Present in the meeting through Video Conferencing: • Promoters and Promoter Group • Public	07 44

This is for your information and record.

Thanking You, Yours Faithfully,

For Vaishali Pharma Limited

VISHWA Digitally signed by VISHWA BIPINBHAI MEKHIA DN: c=IN, o=Personal, postalCode=400064, st=Maharashtra, BIPINBHAI serialNumber=FA5040B8201CBFC67B123D 0D6135EEE19949B54168B2156228E4F1A49 6F012E8, cn=VISHWA BIPINBHAI MEKHIA MEKHIA Date: 2025.09.22 16:44:01 +05'30'

Vishwa Mekhia

Company Secretary Cum Compliance Officer